Skip to main content

Calamos Advisors LLC

SEC CIK
0001316507
Latest filing
Jul 31, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Calamos Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q1 2025)
0
Sold out in Q1 2025
Value
$0
% of portfolio
0.0%
Quarters held
16
Since Q1 2021
Holdings of ELV by Calamos Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20250$00.0%−24,774−100.0%Sold outHolders
Q4 202424,774$9.14M<0.1%+131+0.5%AddedHolders
Q3 202424,643$12.8M0.1%+299+1.2%AddedHolders
Q2 202424,344$13.2M0.1%+184+0.8%AddedHolders
Q1 202424,160$12.5M0.1%+132+0.5%AddedHolders
Q4 202324,028$11.3M0.1%+156+0.7%AddedHolders
Q3 202323,872$10.4M0.1%+146+0.6%AddedHolders
Q2 202323,726$10.5M0.1%+72+0.3%AddedHolders
Q1 202323,654$10.9M0.1%+57+0.2%AddedHolders
Q4 202223,597$12.1M0.1%+96+0.4%AddedHolders
Q3 202223,501$10.7M0.1%−18,704−44.3%ReducedHolders
Q2 202242,205$20.4M0.1%+16,315+63.0%AddedHolders
Q1 202225,890$12.7M<0.1%+7,020+37.2%AddedHolders
Q4 202118,870$8.75M<0.1%00.0%UnchangedHolders
Q3 202118,870$7.04M<0.1%00.0%UnchangedHolders
Q2 202118,870$7.21M<0.1%00.0%UnchangedHolders
Q1 202118,870$6.77M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.